A phase II study of sequential decitabine and rapamycin in acute myelogenous leukemia. Liesveld JL, Baran A, Azadniv M, Misch H, et al. Leuk Res 2021;112:106749.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liesveld JL, Baran A, Azadniv M, Misch H, et al. A phase II study of sequential decitabine and rapamycin in acute myelogenous leukemia. Leuk Res 2021;112:106749.
PMID: 34839054